In a recent study published in the Proceedings of the National Academy of Sciences, researchers developed a fully synthetic platform for nanobody generation. Biologics have been increasingly used for ...
BOSTON, June 1, 2024 /PRNewswire/ -- Immunocan announces significant progress in the construction of its alpaca-derived nanobody discovery platform, ImmuAlpaca® mouse. The IGH-VDJ genes in the mouse ...
Peer-reviewed study in ACS Biomacromolecules demonstrates modular VHH potency, cross-variant therapeutic activity, and a newly described immune-priming mechanism; MindWalk holds first right to ...
Shaperon and Dong-A ST aim to maximize synergy through collaboration between Shaperon's nanobody development platform technology and Dong-A ST's antibody commercialization technology. The joint ...
FREMONT, Calif. and MENLO PARK, Calif., June 20, 2023 (GLOBE NEWSWIRE) -- Alamar Biosciences, a company powering precision proteomics to enable the earliest detection of diseases, and Frazier Life ...
BEIJING--(BUSINESS WIRE)--Biocytogen Pharmaceuticals (Beijing) Co., Ltd. ("Biocytogen", HKEX: 02315) today officially launched its fully human heavy chain antibody platform, RenNano™. RenNano™ is the ...
A research team led by Prof. Xu Pingyong from the Institute of Biophysics of the Chinese Academy of Sciences has developed an innovative approach to visualize and rapidly screen small peptide knockins ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results